Unmatched Access, Unprecedented Opportunity

AnaBios offers early human insights into the drug development process and is redefining “First-in-Human” studies. Leveraging extensive knowledge of human tissue procurement and strategic utilization, AnaBios provides the unprecedented opportunity to de-risk drug development programs by assessing the safety and efficacy of drugs directly in human tissues and cells at the preclinical stage.

Discover the benefits of clinically-predictive human data at the pre-clinical stage.

Predicting Human Efficacy

Determine the potential and selectivity of novel compounds in human ex vivo models.

Predicting Safety and Toxicity in Humans

Predict toxicity risks and safety of preclinical molecules, as well as de-convolute clinical adverse effects.